Navigation Links
Researchers Have Identified Subgroup Sensitive to the Drug Cisplatin

in, a drug used to treat several other types of cancer, but whether the more common sporadic triple-negative tumors shared that sensitivity was unknown. The current study was designed to answer that question and to investigate the mechanism underlying cisplatin sensitivity.

The research team focused on the function of p63, a protein that plays a role in normal breast development and is related to the common tumor suppressor p53. They analyzed tissue samples from triple-negative breast tumors and normal breast tissues for the expression of several forms of p63 and another related protein called p73, known to promote the cell-death process called apoptosis.

The researchers found that a significant number of triple-negative tumors overexpress particular forms of p63 and p73, a pattern not seen in other types of breast cancers. Using an RNA interference system to inhibit the action of p63, they showed that the protein stimulates tumor growth by interfering with p73’s normal ability to induce cell death. Cisplatin was found to break up the binding of p63 to p73 and reactivate the cell-death process.

"The most important finding was that, if the tumor cells did not express both p63 and p73, the cells were not sensitive to cisplatin," says Ellisen. "These results suggest that testing p63 and p73 levels in patients’ tumors might help predict whether they would benefit from cisplatin therapy." Ellisen is an assistant professor of Medicine at Harvard Medical School.

The clinical trial to investigate the role of p63/p73 expression in determining cisplatin sensitivity will be led by MGH researchers through the Dana-Farber/Harvard Cancer Center. Starting in Boston in the coming weeks, the trial will be open to patient with advanced triple-negative breast cancer and eventually will be offered at other U.S. cancer research centers.

Source-Eurekalert
SM
'"/>




Page: 1 2

Related medicine news :

1. Researchers urge caution in using ear tube surgery
2. Researchers Scale to assess the Severity of Epilepsy in Kids
3. Researchers trick Alzheimers Enzyme
4. Researchers find new HIV hiding place
5. New Hair in 15 Days Could Now Be A Possibility Say Researchers
6. Researchers developed world’s smallest toothbrus
7. Researchers discover receptor cells that can cause epilepsy
8. 15 Anti-SARS Drugs Identified By China-Europe Team of Researchers
9. Researchers reversed the process of memory loss
10. Researchers Identify Key Gene That May Help Brain Treatment
11. Researchers Discover Protein That Causes Malaria
Post Your Comments:
(Date:12/14/2009)... Dec. 14 Anthem Blue Cross announced ... intends to award Anthem the Tri-County Commercial contract renewal ... Kings and Madera Counties. This award is the second ... country this year. ,, "The award of this contract ... to deliver on the promise made to residents in ...
(Date:12/14/2009)... in 2,000 people in the United States get a sinus ... , Ms. Wilcox,s tumor was a classic case. She had ... for blocked sinuses. , "For several months, I could not ... resident of Goldthwaite, a town of less than 2,000 in ... but I didn,t take that as something terrible. I never ...
(Date:12/14/2009)... of urban teenage girls may acquire at least one ... years of becoming sexually active, according to an Indiana ... , The study appears in the December 2009 issue ... , The researchers followed 381 girls enrolled at ages ... with the organisms that cause chlamydia, gonorrhea and trichomoniasis ...
(Date:12/14/2009)... the December issue of Mayo Clinic Proceedings , ... This retrospective study is the largest ever conducted in ... a serious disorder that disrupts the body,s normal production ... the bone marrow, leading to severe anemia, weakness, fatigue ... "In the past 20 years, management of primary myelofibrosis ...
(Date:12/14/2009)... of medication-related problems, including under treatment, suboptimal drugs, suboptimal ... their quality of life. Now new research (1), from ... of North Carolina at Chapel Hill shows that blacks ... medical regimens is a particular issue for this group. ... disparities in the quality of medication use appears this ...
Breaking Medicine News(10 mins):Health News:Anthem Blue Cross Wins Third Largest Medicaid Managed Care Contract Renewal in the Country 2Health News:Minimally invasive surgery removes sinus tumor without facial disfiguration 2Health News:IU study: Half of urban teen girls acquire STIs within 2 years of first sexual activity 2Health News:Racial differences in medication use 2
... doctors, nurses and health visitors in Lancashire is soon to ... would also stop staff from having tight clothes//, unusual hairstyles ... Hospitals NHS Trust it wanted a "corporate image which presents ... MP has labeled the policy "completely daft". ,Lynn ...
... the capital Thursday taking the death toll in India due to ... fall in the number of fresh cases. ,The number ... only 74 cases being reported Wednesday across the country, including 63 ... ,Officials said it was easily one of the lowest reported ...
... relatively shorter waiting periods as compared to the rest of ... for// the residents, the reality is that the average period ... year. The Fraser Institute in its 16th annual rating of ... an average of 17.8 weeks for treatment after being referred ...
... the World Health Organisation (WHO), shortage of adequate testing ... million people getting affected by tuberculosis// every year. ... for developing diagnostics in the low and middle-income countries, ... and around 1.7 million lives are lost every year. ...
... chest scans that screen smokers for lung cancer can save lives, ... women for breast cancer,// according to a recent US study. ... detected early by CT scans and removed had an estimated 10-year ... 70% who typically survive, and a lot better than the dismal ...
... stumbled upon reasons to prove that two migratory birds, the ... be// vulnerable and prone to infection with the highly ... to transmit the deadly bird flu. ,In an ... the dreaded Avian flu which had most parts of the ...
Other Medicine News:Health News:Scans Aid in Early Lung Cancer Detection 2
(Date:12/14/2009)... 14 Environmental health advocates hope that ... health hazards of bisphenol A (BPA), a synthetic ... harm and other illnesses, in time for Christmas. ... , staff scientist, Natural Resources Defense Council ... for medical advice, FDA must rely on the ...
(Date:12/14/2009)... Conn., ,Dec. 14 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, ... that it had received a complete response letter ... related to its New Drug Application ("NDA") for ... The letter indicates that the FDA cannot approve ... provides recommendations to address remaining issues. ,, Alan ...
(Date:12/14/2009)... CLAREMONT, Calif., Dec. 14 The ... College today released the analysis of social ... companies world-wide. The report contains a compilation ... the environmental and social reporting of the ... intent, and performance for both environmental and ...
Breaking Medicine Technology:Toxic Chemical bisphenol A Still Not Banned By FDA; Schumer, Gillibrand Call for Ban; Govt Official Warns Public 2Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration 2Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration 3New Report Grades Sustainability Reporting of Top Pharmaceutical Companies 2New Report Grades Sustainability Reporting of Top Pharmaceutical Companies 3Hospital Infection Prevention Resources Cut Study Says 48288 1Hospital Infection Prevention Resources Cut Study Says 48288 2Hospital Infection Prevention Resources Cut Study Says 48288 3BayCare Health System Sleep Disorder Centers Offer Help for Sleepless Nights 48286 1BayCare Health System Sleep Disorder Centers Offer Help for Sleepless Nights 48286 2BayCare Health System Sleep Disorder Centers Offer Help for Sleepless Nights 48286 3Abbott Announces New EAS 28R 29 Myoplex 28R 29 Strength Formula Nutrition Shake and Debuts Bottle Packaging 48284 1Abbott Announces New EAS 28R 29 Myoplex 28R 29 Strength Formula Nutrition Shake and Debuts Bottle Packaging 48284 2Abbott Announces New EAS 28R 29 Myoplex 28R 29 Strength Formula Nutrition Shake and Debuts Bottle Packaging 48284 3Abbott Announces New EAS 28R 29 Myoplex 28R 29 Strength Formula Nutrition Shake and Debuts Bottle Packaging 48284 4Abbott Announces New EAS 28R 29 Myoplex 28R 29 Strength Formula Nutrition Shake and Debuts Bottle Packaging 48284 5
... Importance of DHA/ARA in Infant Diet, EVANSVILLE, Ind., ... olds who had been fed Enfamil LIPIL infant,formula exclusively ... the,longest-term analysis of its kind to demonstrate breastfed-equivalent,visual and ... in the journal Early Human Development, was funded by ...
... PREZISTA/ritonavir data presented at ICAAC -, BRIDGEWATER, ... ongoing,randomized, controlled, open-label Phase 3 study showed that ... investigational dose of,PREZISTA(TM) (darunavir) 800 mg (two 400 ... TRUVADA(R)(1) (emtricitabine and tenofovir disoproxil,fumarate) reached an undetectable ...
Other Medicine Technology:New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies 2New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies 3New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 2New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 3New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 4New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 5New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 6New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 7
Solid State Manometry Catheter Accessory., ,Manometric calibrators are required for calibration of solid state catheters., ,Each type of catheter requires a unique calibrator....
... The programmer for the ITREL 3 ... programmer and the Model 7457 MemoryMod ... indicated for the treatment of chronic nausea ... drug therapies are not providing adequate relief ...
... influenza A and B has ... the availability of effective antiviral ... using Clearview Exact Influenza A ... reduced hospital stays, antimicrobial use ...
... Contrast sensitivity is the ability ... large but faint targets. There are,some ... without impairing visual acuity,and the test ... these conditions. However, reduced contrast,sensitivity and ...
Medicine Products: